me 3221 has been researched along with enalapril in 2 studies
Studies (me 3221) | Trials (me 3221) | Recent Studies (post-2010) (me 3221) | Studies (enalapril) | Trials (enalapril) | Recent Studies (post-2010) (enalapril) |
---|---|---|---|---|---|
7 | 0 | 0 | 6,311 | 1,924 | 859 |
Protein | Taxonomy | me 3221 (IC50) | enalapril (IC50) |
---|---|---|---|
Angiotensin-converting enzyme | Homo sapiens (human) | 0.3536 | |
Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 2.7083 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 1.2 | |
Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.14 | |
Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abe, M; Hachisu, M; Hui, C; Konno, F; Nagura, J; Yamamoto, M; Yasuda, S | 1 |
Hachisu, M; Hui, C; Konno, F; Nagura, J; Yamamoto, M; Yasuda, S | 1 |
2 other study(ies) available for me 3221 and enalapril
Article | Year |
---|---|
ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Brain; Cerebrovascular Disorders; Enalapril; Heart; Hypertension; Imidazoles; Kidney; Losartan; Male; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles | 1996 |
Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |